Astellas Pharma SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Astellas Pharma analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Astellas Pharma SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Astellas Pharma to benchmark its business & performance as compared to the competitors and industry. As of 2020, Astellas Pharma is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Astellas Pharma competitors and includes Astellas Pharma target market, segmentation, positioning & Unique Selling Proposition (USP).

Astellas Pharma SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Astellas Pharma Brand Analysis
Parent Company

Astellas Pharma

Category

Pharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

Leading light for life; Changing tomorrow

USP

They are research driven organization operating in over 40 countries with thrust on ethical pharmaceuticals.

Astellas Pharma STP
Astellas Pharma Segmentation

Urology, organ transplant, infection, immunology segment

Target Group

Medical representatives, healthcare professionals

Astellas Pharma Positioning

They want to contribute in improving health of people through innovative & reliable healthcare

Astellas Pharma SWOT Analysis
Astellas Pharma Strengths

Below are the Strengths in the SWOT Analysis of Astellas Pharma:

1. Strong product pipeline supported by a workforce of over 14,000

2. Astellas pharma has management policies with strong emphasis on CSR

3. Considerable presence in organ transplant segment

4. Well defined global compliance structure which reduces regulatory issues
5. Presence in approx 15 countries
6. Expertise R&D in infectious diseases, diabetes, gastrointestinal diseases etc

Astellas Pharma Weaknesses

Here are the weaknesses in the Astellas Pharma SWOT Analysis:

1. Limited presence in emerging markets and overdependence on the Japanese market

2.High reliance on few blockbuster drugs like Prograf, Harrnal, Vesicare

Astellas Pharma Opportunities

Following are the Opportunities in Astellas Pharma SWOT Analysis:

1. Increasing global ageing population

2. Increase in health awareness
3. Tie-ups with global pharma brands and hospitals

Astellas Pharma Threats

The threats in the SWOT Analysis of Astellas Pharma are as mentioned:

1. Natural disasters in Japan which disrupts major business operations

2. Reduction in spending on healthcare

3. Global economic slowdown

Astellas Pharma Competition
Competitors

Below are the top 3 Astellas Pharma competitors:

1. Abbott laboratories
2. Amgen

3. Allergan Inc.


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Astellas Pharma. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin